{"id":"556987-4844","orgnr":"556987-4844","name":"Lecare AB","name_registered_on":"2014-10-23","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2014-10-23","business_description":"Föremålet för bolagets verksamhet är konsultverksamhet inom läkemedelsutveckling, sjukdomsdiagnostik, biomarkörsutveckling och sjukdomsprevention. Rådgivning inom strategier för läkemedelsutveckling, utveckling av affärsplaner för mindre bolag, forskninsstrategier, in och ut-licensieringsprocesser, förebyggande hälsovård, äga och förvalta fast som lös egendom och därmed förenlig verksamhet.","industries":[{"code":"46189","name":"Provisionshandel med annat specialsortiment utom motorfordon"},{"code":"86212","name":"Annan allmän öppen hälso- och sjukvård, ej primärvård"}],"postal_address":{"city":"KOLMÅRDEN","country":"SE","municipality":{"code":"0581","name":"Norrköping"},"county":{"code":"05","name":"Östergötlands län"}},"registered_office":{"municipality":{"code":"0486","name":"Strängnäs"},"county":{"code":"04","name":"Södermanlands län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"1","name":"1 - 499 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"never_registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2024-10-01","to":"2025-09-30","framework":"K2","signed_on":"2026-03-02","documents":{"annual_report":"/v1/documents/17e65dfe-5d1d-4830-bfa6-ba05129ec928.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/11_2.zip"}},{"from":"2023-10-01","to":"2024-09-30","framework":"K2","signed_on":"2025-03-20","documents":{"annual_report":"/v1/documents/d6bf9e93-7dea-4bbb-ad67-fd7ce1195d86.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/13_3.zip"}},{"from":"2022-10-01","to":"2023-09-30","framework":"K2","signed_on":"2024-03-11","documents":{"annual_report":"/v1/documents/1a405dcb-14b2-4ebc-a84a-58321ea55d27.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/11_2.zip"}},{"from":"2021-10-01","to":"2022-09-30","framework":"K2","signed_on":"2023-03-27","documents":{"annual_report":"/v1/documents/a3828f86-52a7-42e9-95ea-41c0c3fdee56.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/13_3.zip"}},{"from":"2020-10-01","to":"2021-09-30","framework":"K2","signed_on":"2022-03-08","documents":{"annual_report":"/v1/documents/161ca03f-f11e-4759-b860-c40c3e482879.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/10_2.zip"}},{"from":"2019-10-01","to":"2020-09-30","framework":"K2","signed_on":"2021-02-26","documents":{"annual_report":"/v1/documents/8b000956-a21e-4e66-85e4-e010db4f4924.xhtml"},"source":{"dataset":"arsredovisningar","file":"2021/12_2.zip"}}],"latest_financials":{"from":"2024-10-01","to":"2025-09-30","scope":"company","currency":"SEK","net_sales":27000,"operating_profit":-29678,"profit_after_financial_items":-28344,"net_profit":-28344,"total_assets":193580,"current_assets":133703,"equity":178082,"share_capital":50000,"unrestricted_equity":128082,"current_liabilities":15498,"cash":78923,"equity_ratio":0.92,"net_sales_growth":0.08,"source":{"annual_report":"2025-09-30","document":"/v1/documents/17e65dfe-5d1d-4830-bfa6-ba05129ec928.xhtml"},"anchors":{"cash":{"text":"78 923","prefix":"Summa kassa och bank","suffix":"103 179"},"current_assets":{"text":"133 703"},"current_liabilities":{"text":"15 498"},"equity":{"text":"178 082","prefix":"kapital"},"equity_ratio":{"text":"92,0"},"net_sales":{"text":"27 000","prefix":"Nettoomsättning"},"operating_profit":{"text":"29 678"},"profit_after_financial_items":{"text":"28 344","suffix":"-25"},"share_capital":{"text":"50 000","prefix":"utgång"},"total_assets":{"text":"193 580","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"128 082","prefix":"344"}}},"officers":{"annual_report":"2025-09-30","signed_on":"2026-03-02","signatories":[{"name":"C*****","role":"Verkställande direktör"}]}}